Diabetic Nephropathy and Proton Pump Inhibitors – Pilot Case-Control Study

INTRODUCTION: Proton pump inhibitors (PPIs) are liberally used over the counter medication and is largely considered safe. Off late, there are many reports that suggest increased incidence of chronic kidney disease with long-term PPI use. PPIs are often prescribed in patients with diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales: Raj, Jeffrey Pradeep, Pinto, Reevan Winston, Tomy, Suraj Kallarakal, Kulkarni, Shruthi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121724/
https://www.ncbi.nlm.nih.gov/pubmed/35603105
http://dx.doi.org/10.4103/ijn.IJN_397_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121724/
https://www.ncbi.nlm.nih.gov/pubmed/35603105
http://dx.doi.org/10.4103/ijn.IJN_397_20

Ejemplares similares